Prehypertensive African-American women have preserved nitric oxide and renal function but high cardiovascular risk

Kidney and Blood Pressure Research

Volumn 33, Issue 4, 2010, Pages 282-290

  Feairheller, Deborah L ^a   Sturgeon, Kathleen M ^a   Diaz, Keith M ^a   Veerabhadrappa, Praveen ^a   Williamson, Sheara T ^a   Crabbe, Deborah L ^b   Brown, Michael D ^a,c  

^a TEMPLE UNIVERSITY   (United States)

^b Division of Cardiology   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

African Americans; High sensitivity C reactive protein; Nitric oxide; Pre hypertension

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; NITRIC OXIDE; SODIUM; SUPEROXIDE DISMUTASE;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CREATININE URINE LEVEL; DIET RESTRICTION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY FUNCTION; OXIDATIVE STRESS; PRIORITY JOURNAL;

AFRICAN AMERICANS; ALBUMINURIA; C-REACTIVE PROTEIN; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION, RENAL; INCIDENCE; KIDNEY; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; PREHYPERTENSION; PREVALENCE; RISK FACTORS; SUPEROXIDE DISMUTASE;

EID: 77954406830     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000317944     Document Type: Article

References (50)

1. Hsu CY, Lin F, Vittinghoff E, Shlipak MG: Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 2003; 14: 2902-2907.
2. Ho KK, Pinsky JL, Kannel WB, Levy D: The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993; 22: 6A-13A.
3. Lloyd-Jones DM, Sutton-Tyrrell K, Patel AS, Matthews KA, Pasternak RC, Everson-Rose SA, Scuteri A, Chae CU: Ethnic variation in hypertension among premenopausal and perimenopausal women: Study of Women's Health Across the Nation. Hypertension 2005; 46: 689-695.
4. Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C: Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 2005; 165: 923-928.
5. Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G: Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 2005; 68: 237-245.
6. Stam F, van Guldener C, Schalkwijk CG, ter Wee PM, Donker AJ, Stehouwer CD: Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. Nephrol Dial Transplant 2003; 18: 892-898.
7. Annuk M, Soveri I, Zilmer M, Lind L, Hulthe J, Fellstrom B: Endothelial function, CRP and oxidative stress in chronic kidney disease. J Nephrol 2005; 18: 721-726.
8. Bautista LE, Lopez-Jaramillo P, Vera LM, Casas JP, Otero AP, Guaracao AI: Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 2001; 19: 857-861.
9. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG: Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 2003; 111: 1201-1209.
10. Maffei A, Poulet R, Vecchione C, Colella S, Fratta L, Frati G, Trimarco V, Trimarco B, Lembo G: Increased basal nitric oxide release despite enhanced free radical production in hypertension. J Hypertens 2002; 20: 1135-1142.
11. Arnal JF, Dinh-Xuan AT, Pueyo M, Darblade B, Rami J: Endothelium-derived nitric oxide and vascular physiology and pathology. Cell Mol Life Sci 1999; 55: 1078-1087.
12. Moncada S, Palmer RM, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
13. Modlinger PS, Wilcox CS, Aslam S: Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin Nephrol 2004; 24: 354-365.
14. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
15. Pletcher MJ, Bibbins-Domingo K, Lewis CE, Wei GS, Sidney S, Carr JJ, Vittinghoff E, Mc-Culloch CE, Hulley SB: Prehypertension during young adulthood and coronary calcium later in life. Ann Intern Med 2008; 149: 91-99.
16. Hsia J, Margolis KL, Eaton CB, Wenger NK, Allison M, Wu L, LaCroix AZ, Black HR: Prehypertension and cardiovascular disease risk in the Women's Health Initiative. Circulation 2007; 115: 855-860.
17. Reynolds K, Gu D, Muntner P, Kusek JW, Chen J, Wu X, Duan X, Chen CS, Klag MJ, Whelton PK, He J: A population-based, prospective study of blood pressure and risk for end-stage renal disease in China. J Am Soc Nephrol 2007; 18: 1928-1935.
18. Higashikuni Y, Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M: Relationship between blood pressure and chronic kidney disease in the Japanese population: the lower the better even in individuals without hypertension? Hypertens Res 2008; 31: 213-219.
19. Munkhaugen J, Lydersen S, Wideroe TE, Hallan S: Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway. Am J Kidney Dis 2009; 54: 638-646.
20. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O'Brien E: Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348: 2407-2415.
21. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ: Recommendations for blood pressure measurement in humans and experimental animals. 1. Blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005; 45: 142-161.
22. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254.
23. Schmidt RJ, Baylis C: Total nitric oxide production is low in patients with chronic renal disease. Kidney Int 2000; 58: 1261-1266.
24. Kim SW, Lee J, Paek YW, Kang DG, Choi KC: Decreased nitric oxide synthesis in rats with chronic renal failure. J Korean Med Sci 2000; 15: 425-430.
25. Lyamina NP, Dolotovskaya PV, Lyamina SV, Malyshev IY, Manukhina EB: Nitric oxide production and intensity of free radical processes in young men with high normal and hypertensive blood pressure. Med Sci Monit 2003; 9:CR304-CR310.
26. Majid DS, Navar LG: Nitric oxide in the control of renal hemodynamics and excretory function. Am J Hypertens 2001; 14: 74S-82S.
27. Alderton WK, Cooper CE, Knowles RG: Nitric oxide synthases: structure, function and inhibition. Biochem J 2001; 357: 593-615.
28. Ruan J, Xie Q, Hutchinson N, Cho H, Wolfe GC, Nathan C: Inducible nitric oxide synthase requires both the canonical calmodulin-binding domain and additional sequences in order to bind calmodulin and produce nitric oxide in the absence of free Ca 2+ . J Biol Chem 1996; 271: 22679-22686.
29. Vaziri ND, Ni Z, Oveisi F: Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 1998; 31: 1248-1254.
30. Kumar U, Chen J, Sapoznikhov V, Canteros G, White BH, Sidhu A: Overexpression of inducible nitric oxide synthase in the kidney of the spontaneously hypertensive rat. Clin Exp Hypertens 2005; 27: 17-31.
31. Kumar U, Shin Y, Wersinger C, Patel Y, Sidhu A: Diminished expression of constitutive nitric oxide synthases in the kidney of spontaneously hypertensive rat. Clin Exp Hypertens 2003; 25: 271-282.
32. Suzuki H, Ikenaga H, Hishikawa K, Nakaki T, Kato R, Saruta T: Increases in NO2-/NO3-excretion in the urine as an indicator of the release of endothelium-derived relaxing factor during elevation of blood pressure. Clin Sci (Lond) 1992; 82: 631-634.
33. Dubey RK, Boegehold MA, Gillespie DG, Rosselli M: Increased nitric oxide activity in early renovascular hypertension. Am J Physiol 1996; 270:R118-R124.
34. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
35. Rizzo M, Corrado E, Coppola G, Muratori I, Mezzani A, Novo G, Novo S: The predictive role of C-reactive protein in patients with hypertension and subclinical atherosclerosis. Intern Med J 2009; 39: 539-545.
36. Xu T, Ju Z, Tong W, Hu W, Liu Y, Zhao L, Zhang Y: Relationship of C-reactive protein with hypertension and interactions between increased C-reactive protein and other risk factors on hypertension in Mongolian people, China. Circ J 2008; 72: 1324-1328.
37. Mule G, Cottone S, Cusimano P, Riccobene R, Palermo A, Geraci C, Nardi E, Bellavia T, Foraci AC, Cerasola G: The association of microalbuminuria with aortic stiffness is independent of C-reactive protein in essential hypertension. Am J Hypertens 2009; 22: 1041-1047.
38. Sung KC, Suh JY, Kim BS, Kang JH, Kim H, Lee MH, Park JR, Kim SW: High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens 2003; 16: 429-433.
39. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-843.
40. Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A, Matthews KA, Johnston J, Sowers MR, Sternfeld B, Pasternak RC, Chae CU: Ethnic differences in C-reactive protein concentrations. Clin Chem 2008; 54: 1027-1037.
41. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, Dhillon B, Weisel RD, Li RK, Mickle DA, Stewart DJ: A selffulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002; 106: 913-919.
42. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I: Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002; 106: 1439-1441.
43. Farbom P, Wahlstrand B, Almgren P, Skrtic S, Lanke J, Weiss L, Kjeldsen S, Hedner T, Melander O: Interaction between renal function and microalbuminuria for cardiovascular risk in hypertension: the Nordic Diltiazem Study. Hypertension 2008; 52: 115-122.
44. Clausen P, Jensen JS, Jensen G, Borch-Johnsen K, Feldt-Rasmussen B: Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 2001; 103: 1869-1874.
45. Flack JM, Duncan K, Ohmit SE, Quah R, Liu X, Ramappa P, Norris S, Hedquist L, Dudley A, Nasser SA: Influence of albuminuria and glomerular filtration rate on blood pressure response to antihypertensive drug therapy. Vasc Health Risk Manag 2007; 3: 1029-1037.
46. Siragy HM, Xue C, Webb RL: Beneficial effects of combined benazepril-amlodipine on cardiac nitric oxide, cGMP, and TNF-alpha production after cardiac ischemia. J Cardiovasc Pharmacol 2006; 47: 636-642.
47. Ghiadoni L, Magagna A, Kardasz I, Taddei S, Salvetti A: Fixed dose combination of perindopril and indapamide improves peripheral vascular function in essential hypertensive patients. Am J Hypertens 2009; 22: 506-512.
48. Simic DV, Mimic-Oka J, Pljesa-Ercegovac M, Savic-Radojevic A, Opacic M, Matic D, Ivanovic B, Simic T: Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertension. J Hum Hypertens 2006; 20: 149-155.
49. Redon J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, Saez GT: Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 2003; 41: 1096-1101.
50. Chrysohoou C, Panagiotakos DB, Pitsavos C, Skoumas J, Economou M, Papadimitriou L, Stefanadis C: The association between pre-hypertension status and oxidative stress markers related to atherosclerotic disease: the ATTICA study. Atherosclerosis 2007; 192: 169-176.